Minerva Neurosciences, Inc
4.3.2026 13:00:00 CET | Globenewswire | Press release
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Citizens Life Sciences Conference being held March 10-11, 2026 in Miami, FL.
| The Citizens Life Sciences Conference | |
| Format: | Company presentation |
| Day/Time: | Tuesday, March 10 at 9:35 AM ET |
| Webcast: | https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/SKrutqyvQVtnaKJDseE6uU |
If you are interested in meeting with the Minerva team during the conference, please reach out to your Citizens Bank representative.
A replay of the presentation will be available on the Company's Investors & Media Events and Presentations webpage for ninety days following the event.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company’s website.
Contacts:
Investor inquiries:
Frederick Ahlholm
Chief Financial Officer
Minerva Neurosciences, Inc.
FAhlholm@minervaneurosciences.com
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
NTG Nordic Transport Group A/S4.3.2026 13:53:41 CET | Press release
Transactions in connection with share buy-back program
NTG Nordic Transport Group A/S4.3.2026 13:52:05 CET | Press release
NTG Nordic Transport Group Annual Report for 2025
NTG Nordic Transport Group A/S4.3.2026 13:47:15 CET | Press release
NTG Nordic Transport Group A/S – Update on medium-term ambition
Dyadic International, Inc.4.3.2026 13:20:00 CET | Press release
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
The Descartes Systems Group Inc4.3.2026 12:45:00 CET | Press release
Descartes Expands AI Innovation on Global Logistics Network with AI Agents for Freight Visibility
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom